Management of Atrial Fibrillation With Flecainide : the AFFLEC Study
NCT ID: NCT02190175
Last Updated: 2018-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2014-06-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Current Clinical Practice in the Management of Atrial Fibrillation in Greece: the MANAGE-AF Study
NCT01317602
Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.
NCT00408473
The Use of Flecainide for Treatment of Atrial Fibrillation
NCT05084495
Polish Atrial Fibrillation (POL-AF) Registry
NCT04419012
Beta Blockers Plus Intravenous Flecainide for Paroxysmal Atrial Fibrillation: a Real-world Chios Registry (BETAFLEC-CHIOS)
NCT04991896
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation
* study of flecainide in ST interval
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients able to give informed consent
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hellenic Cardiovascular Research Society
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erythros Stavros Hospital
Athens, , Greece
University Hospital of Larisa
Larissa, , Greece
AHEPA University Hospital
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AFFLEC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.